Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
28.18
-1.45 (-4.88%)
Mar 31, 2025, 10:09 AM EDT - Market open
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $1.83 billion as of March 31, 2025. Its market cap has decreased by -29.22% in one year.
Market Cap
1.83B
Enterprise Value
1.16B
1-Year Change
-29.22%
Ranking
Category
Stock Price
$28.18
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $1.83B, an increase of 119.27%. That is a compound annual growth rate of 18.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.92B | -26.17% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.66B |
| UnitedHealth Group | 471.76B |
| Johnson & Johnson | 394.47B |
| AbbVie | 362.98B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 226.85B |
| Merck & Co. | 225.37B |
| AstraZeneca | 225.00B |